ES2182996T3 - Composiciones farmaceuticas que comprenden un inhibidor de proteinasa y un monglicerido. - Google Patents

Composiciones farmaceuticas que comprenden un inhibidor de proteinasa y un monglicerido.

Info

Publication number
ES2182996T3
ES2182996T3 ES96921929T ES96921929T ES2182996T3 ES 2182996 T3 ES2182996 T3 ES 2182996T3 ES 96921929 T ES96921929 T ES 96921929T ES 96921929 T ES96921929 T ES 96921929T ES 2182996 T3 ES2182996 T3 ES 2182996T3
Authority
ES
Spain
Prior art keywords
monglicerido
pharmaceutical compositions
proteinase inhibitor
compositions
monoglycered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96921929T
Other languages
English (en)
Inventor
Carole Anne Bailey
Josephine Christine Ferdinando
Navnit Shah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/616,233 external-priority patent/US6008228A/en
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2182996T3 publication Critical patent/ES2182996T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE DESCRIBEN COMPOSICIONES QUE AUMENTAN LA BIODISPONIBILIDAD DE INHIBIDORES DE PROTEINASA. LAS COMPOSICIONES INCLUYEN UN VEHICULO FARMACEUTICAMENTE ACEPTABLE QUE INCLUYE MONOGLICERIDOS DE ACIDOS GRASOS DE CADENA DE LONGITUD MEDIA.
ES96921929T 1995-06-06 1996-06-04 Composiciones farmaceuticas que comprenden un inhibidor de proteinasa y un monglicerido. Expired - Lifetime ES2182996T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46849395A 1995-06-06 1995-06-06
US08/616,233 US6008228A (en) 1995-06-06 1996-05-07 Pharmaceutical compositions containing proteinase inhibitors

Publications (1)

Publication Number Publication Date
ES2182996T3 true ES2182996T3 (es) 2003-03-16

Family

ID=27042422

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96921929T Expired - Lifetime ES2182996T3 (es) 1995-06-06 1996-06-04 Composiciones farmaceuticas que comprenden un inhibidor de proteinasa y un monglicerido.

Country Status (27)

Country Link
EP (1) EP0831826B1 (es)
JP (1) JP3238412B2 (es)
CN (1) CN1092960C (es)
AT (1) ATE226075T1 (es)
AU (1) AU709796B2 (es)
BG (1) BG63711B1 (es)
BR (1) BR9610842A (es)
CA (1) CA2224125C (es)
CY (1) CY2373B1 (es)
CZ (1) CZ292192B6 (es)
DE (1) DE69624354T2 (es)
DK (1) DK0831826T3 (es)
EA (1) EA001413B1 (es)
ES (1) ES2182996T3 (es)
HK (1) HK1010136A1 (es)
HU (1) HU223899B1 (es)
IL (1) IL122353A0 (es)
IS (1) IS2661B (es)
MX (1) MX9709193A (es)
NO (1) NO324531B1 (es)
NZ (1) NZ311646A (es)
OA (1) OA10546A (es)
PL (1) PL184820B1 (es)
PT (1) PT831826E (es)
SK (1) SK282121B6 (es)
TR (1) TR199701541T1 (es)
WO (1) WO1996039142A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0999838T3 (da) 1997-07-29 2002-07-08 Upjohn Co Selv-emulgerende formulering for lipofile forbindelser
BR9810729B1 (pt) 1997-07-29 2010-07-13 composição farmacêutica para compostos lipofìlicos ácidos disposta como uma formulação auto-emulsificante.
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
ATE537811T1 (de) * 1999-02-08 2012-01-15 Intarcia Therapeutics Inc Stabile nicht wässerige einphasige visköse vehikel und formulierungen die diese vehikel verwenden
US6956048B2 (en) 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
BR0202252A (pt) 2002-06-12 2004-06-29 Cristalia Prod Quimicos Farm Composição farmacêutica solúvel estável para administração de inibidores da hiv protease e processo de obtenção de composições farmacêuticas concentradas para a administração de inibidores da hiv protease
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
CN101453982B (zh) 2006-05-30 2011-05-04 精达制药公司 两件式内部通道渗透递送系统流动调节器
EP2157967B1 (en) 2007-04-23 2013-01-16 Intarcia Therapeutics, Inc Suspension formulations of insulinotropic peptides and uses thereof
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
EP2108705A1 (en) 2008-04-08 2009-10-14 Universität Duisburg-Essen Method for analysing the epigenetic status of the HtrA 1 gene in a biological sample
CN104323981B (zh) 2009-09-28 2019-03-12 精达制药公司 基本稳态药物递送的快速建立和/或终止
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
WO2016196851A2 (en) 2015-06-03 2016-12-08 Intarcia Therapeutics, Inc. Implant placement and removal systems
MX2018014016A (es) 2016-05-16 2019-08-01 Intarcia Therapeutics Inc Polipéptidos selectivos del receptor de glucagón y métodos para utilizarlos.
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8927913D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Amino acid derivatives
IL110752A (en) * 1993-09-13 2000-07-26 Abbott Lab Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor

Also Published As

Publication number Publication date
CY2373B1 (en) 2004-06-04
MX9709193A (es) 1998-03-31
IL122353A0 (en) 1998-04-05
EP0831826A1 (en) 1998-04-01
EA001413B1 (ru) 2001-02-26
BR9610842A (pt) 1999-07-13
DE69624354T2 (de) 2003-06-05
BG63711B1 (bg) 2002-10-31
SK162797A3 (en) 1998-05-06
OA10546A (en) 2002-05-29
CZ380397A3 (cs) 1998-03-18
TR199701541T1 (xx) 1998-03-21
NO975665D0 (no) 1997-12-05
BG102106A (en) 1998-08-31
CA2224125C (en) 2004-09-28
EP0831826B1 (en) 2002-10-16
IS2661B (is) 2010-08-15
CN1186434A (zh) 1998-07-01
IS4627A (is) 1997-12-04
HK1010136A1 (en) 1999-06-17
HU223899B1 (hu) 2005-03-29
PL323860A1 (en) 1998-04-27
NO324531B1 (no) 2007-11-12
EA199800023A1 (ru) 1998-08-27
AU709796B2 (en) 1999-09-09
CA2224125A1 (en) 1996-12-12
PL184820B1 (pl) 2002-12-31
CN1092960C (zh) 2002-10-23
CZ292192B6 (cs) 2003-08-13
PT831826E (pt) 2003-02-28
AU6300496A (en) 1996-12-24
JPH10507202A (ja) 1998-07-14
JP3238412B2 (ja) 2001-12-17
WO1996039142A1 (en) 1996-12-12
HUP9801905A2 (hu) 1999-05-28
HUP9801905A3 (en) 2001-04-28
NZ311646A (en) 2000-02-28
NO975665L (no) 1998-02-05
DE69624354D1 (de) 2002-11-21
SK282121B6 (sk) 2001-11-06
DK0831826T3 (da) 2003-02-03
ATE226075T1 (de) 2002-11-15

Similar Documents

Publication Publication Date Title
ES2182996T3 (es) Composiciones farmaceuticas que comprenden un inhibidor de proteinasa y un monglicerido.
PT722439E (pt) Inibidores da protease de hiv
DK0869966T3 (da) Prodrugs for thrombin-inhibitorer
FI973360A0 (fi) Uusia dipeptidisiä amidiineja trombiininestäjiksi
NO981965D0 (no) Trombininhibitorer
MA26492A1 (fr) Inhibiteurs de proteases nouveaux et compositions pharmaceutiques les contenant .
UY24248A1 (es) Composiciones farmacéuticas que contienen inhibidores de proteinasa
SE9601556D0 (sv) New pharmaceutical formulation of a thrombin inhibitor for parenteral use
HRP20030983B1 (en) Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid ester
FI962073A (fi) HIV-proteaasin estäjän prodrug-muotoja
HUP9802764A3 (en) Guanidino protease inhibitors
TR199501429A2 (tr) Matriks metaloproteaz inhibitörlerinin yerine gecen 4-biarilpentanoik asitleri ve türevleri
DE69404926D1 (de) Hochdruck-Entladungslampe
DE69526657D1 (de) Niederdruckentladungslampe
DE69606699D1 (de) Hochdruckentladungslampe
DE59603552D1 (de) Hochdruckentladungslampe
DE69633040D1 (de) Inhibitor der hornhaut-vaskularisation
DE69605365D1 (de) Niederdruckentladungslampe
DK0876367T3 (da) Trans apovincaminsyreesterderivater som lægemidler
ECSP961778A (es) Composiciones que incrementan la biodisponibilidad de inhibidores de proteinasa
KR980003762U (ko) 제품 브랜드의 고정 장치
BR9612344A (pt) Inibidores de proteases
KR970019465U (ko) 콤팩트디스크플레어의 디스크 인출장치
KR970025641U (ko) 브라운관의 스포트 불량제거용 소켓
KR970027316U (ko) 폐기물 압축기용 압적부 구조